South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- Emirati Axis Group of Pankaj Oswal claims 29 billion USD from Guinea after loss of mining license
- BEAC: Revenues on the rise to USD 1.05 billion in 2026
- South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
- DRC: Insurance compensations soar to $58 million USD in 2024
- Nigeria: Central Bank raises $10.5 billion on Treasury bills in 2025
- CEMAC: Inflation falls below the community threshold in the third quarter of 2025
- Budget 2026 in Burkina Faso: Revenues of 3,431 billion CFA francs expected for estimated expenses of over 3,918 billion CFA francs
- Suez Canal: Egypt and Japan conclude a $22 million agreement for a rescue ship
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com